BPG is committed to discovery and dissemination of knowledge
Number of total visits
2741229
Number of visits today
954
Number of downloads
2012819
MEMBERSHIP
Cited by in F6Publishing
For:
Xiao Y , Liu Q , Peng N , Li Y , Qiu D , Yang T , Kang R , Usmani A , Amadasu E , Borlongan CV , Yu G . Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer. Cell Transplant 2022;31 :9636897221075749. [PMID: 35168393 DOI: 10.1177/09636897221075749 ] [ Cited by in Crossref: 1] [ Cited by in F6Publishing: 2 ] [ Article Influence: 1.0 ] [ Reference Citation Analysis ]
Number
Citing Articles
1
Chen D , Zhou X , Yan P , Yang C , Li Y , Han L , Ren X . Lipid metabolism reprogramming in colorectal cancer. J Cell Biochem 2023;124 :3-16. [PMID: 36334309 DOI: 10.1002/jcb.30347 ] [ Reference Citation Analysis ]
2
Araújo D , Ribeiro E , Amorim I , Vale N . Repurposed Drugs in Gastric Cancer. Molecules 2022;28 . [PMID: 36615513 DOI: 10.3390/molecules28010319 ] [ Reference Citation Analysis ]
3
Pereira M , Matuszewska K, Glogova A, Petrik J. Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy. Cancers 2022;14 :3500. [DOI: 10.3390/cancers14143500 ] [ Reference Citation Analysis ]
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA California Corporate Number: 3537345
